Axsome Therapeutics Inc (AXSM)
86.59
-4.59
(-5.03%)
USD |
NASDAQ |
Oct 04, 16:00
86.60
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Shareholders Equity (Annual): 190.98M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 190.98M |
| December 31, 2022 | 109.56M |
| December 31, 2021 | 15.63M |
| December 31, 2020 | 113.79M |
| December 31, 2019 | 178.72M |
| December 31, 2018 | 0.9379M |
| Date | Value |
|---|---|
| December 31, 2017 | 16.72M |
| December 31, 2016 | 21.57M |
| December 31, 2015 | 46.44M |
| December 31, 2014 | -3.203M |
| December 31, 2013 | -2.028M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
15.63M
Minimum
2021
190.98M
Maximum
2023
121.74M
Average
113.79M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Krystal Biotech Inc | 778.64M |
| Madrigal Pharmaceuticals Inc | 405.33M |
| Vertex Pharmaceuticals Inc | 17.58B |
| Sarepta Therapeutics Inc | 859.34M |
| Tonix Pharmaceuticals Holding Corp | 105.52M |